JP2005524614A5 - - Google Patents

Download PDF

Info

Publication number
JP2005524614A5
JP2005524614A5 JP2003556023A JP2003556023A JP2005524614A5 JP 2005524614 A5 JP2005524614 A5 JP 2005524614A5 JP 2003556023 A JP2003556023 A JP 2003556023A JP 2003556023 A JP2003556023 A JP 2003556023A JP 2005524614 A5 JP2005524614 A5 JP 2005524614A5
Authority
JP
Japan
Prior art keywords
composition
solvent
corticosteroid
stearate
emulsifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003556023A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005524614A (ja
Filing date
Publication date
Priority claimed from US10/037,360 external-priority patent/US6765001B2/en
Application filed filed Critical
Publication of JP2005524614A publication Critical patent/JP2005524614A/ja
Publication of JP2005524614A5 publication Critical patent/JP2005524614A5/ja
Withdrawn legal-status Critical Current

Links

JP2003556023A 2001-12-21 2002-12-12 副腎皮質ステロイド送達を増進するための組成物および方法 Withdrawn JP2005524614A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/037,360 US6765001B2 (en) 2001-12-21 2001-12-21 Compositions and methods for enhancing corticosteroid delivery
PCT/US2002/039882 WO2003055445A2 (en) 2001-12-21 2002-12-12 Compositions and methods for enhancing corticosteriod delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010172249A Division JP2010280689A (ja) 2001-12-21 2010-07-30 副腎皮質ステロイド送達を増進するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2005524614A JP2005524614A (ja) 2005-08-18
JP2005524614A5 true JP2005524614A5 (cg-RX-API-DMAC7.html) 2006-01-26

Family

ID=21893928

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003556023A Withdrawn JP2005524614A (ja) 2001-12-21 2002-12-12 副腎皮質ステロイド送達を増進するための組成物および方法
JP2010172249A Pending JP2010280689A (ja) 2001-12-21 2010-07-30 副腎皮質ステロイド送達を増進するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010172249A Pending JP2010280689A (ja) 2001-12-21 2010-07-30 副腎皮質ステロイド送達を増進するための組成物および方法

Country Status (9)

Country Link
US (8) US6765001B2 (cg-RX-API-DMAC7.html)
EP (2) EP1465636A4 (cg-RX-API-DMAC7.html)
JP (2) JP2005524614A (cg-RX-API-DMAC7.html)
CN (1) CN1617730A (cg-RX-API-DMAC7.html)
BR (1) BR0215254A (cg-RX-API-DMAC7.html)
CA (1) CA2471041C (cg-RX-API-DMAC7.html)
IL (1) IL162581A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04006014A (cg-RX-API-DMAC7.html)
WO (1) WO2003055445A2 (cg-RX-API-DMAC7.html)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630152B2 (en) * 1999-04-07 2003-10-07 Shen Wei (Usa), Inc. Aloe vera glove and manufacturing method
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US7897587B2 (en) 2004-09-03 2011-03-01 Nycomed Us Inc. Topical dermatological formulations and use thereof
BRPI0612448A2 (pt) 2005-05-09 2010-11-23 Foamix Ltd composição espumosa de sacarìdeo
AU2006244245B2 (en) * 2005-05-10 2010-11-18 Alcon, Inc. Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
SI1885336T1 (sl) * 2005-05-10 2009-08-31 Alcon Inc Suspenzijske formulacije, ki obsegajo aktivno sestavino, poloksamerni ali meroksapolni surfaktant in glikol, in njihova uporaba za pripravo zdravila za zdravljenje oftalmičnih motenj
WO2007046315A1 (ja) * 2005-10-17 2007-04-26 Nisshin Kyorin Pharmaceutical Co., Ltd. 皮膚外用剤
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
MX2008007439A (es) * 2005-12-09 2009-01-22 Nycomed Inc Formulaciones glucocorticosteroides topicas.
US20070179121A1 (en) * 2006-02-02 2007-08-02 Plott R T Method of treating pediatric patients with corticosteroids
EP1998742A2 (en) * 2006-03-08 2008-12-10 Nuviance, INC. Transdermal drug delivery compositions and topical compositions for application on the skin
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US8413435B2 (en) * 2006-06-13 2013-04-09 Wescast Industries, Inc. Exhaust manifolds including heat shield assemblies
SI2494959T1 (sl) * 2006-07-05 2015-04-30 Foamix Pharmaceuticals Ltd. Penilno sredstvo dikarboksilne kisline in njega farmacevtski sestavki
GB2443161B (en) * 2006-10-28 2011-03-23 Nupharm Lab Ltd Clobetasol spray
GB2443162B (en) * 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
CN101848702B (zh) 2006-12-01 2013-07-17 安特里奥公司 两亲实体纳米粒子
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
JP2010514789A (ja) * 2006-12-27 2010-05-06 アベール ファーマシューティカルズ インコーポレイテッド 副腎皮質ステロイド投与のための経皮的方法及びパッチ
WO2008115224A2 (en) * 2007-03-20 2008-09-25 Bayer Healthcare Llc Method of analyzing an analyte
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20090298803A1 (en) * 2008-05-28 2009-12-03 Glenmark Generics Ltd. Pharmaceutical composition comprising fluocinonide
MX2010013562A (es) * 2008-06-26 2011-02-15 Anterios Inc Aplicacion dermica.
TW201035054A (en) * 2009-02-27 2010-10-01 Lundbeck & Co As H Methods of administering (4aR, 10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol and pharmaceutical compositions thereof
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
AR077490A1 (es) * 2009-07-21 2011-08-31 Novartis Ag Composiciones farmaceuticas topicas para el tratamiento de una condicion hiperproliferativa de la piel
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) * 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
JP6131194B2 (ja) * 2011-01-24 2017-05-17 アンテリオス, インコーポレイテッド 皮膚科学的症状を処置するためのエンプティナノ粒子組成物およびその使用
GB201110632D0 (en) * 2011-06-22 2011-08-03 King S College London Drug delivery formulations
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
JP5820206B2 (ja) * 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
US8962028B2 (en) 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method
HK1223300A1 (zh) 2013-06-03 2017-07-28 Tolmar, Inc. 皮质类固醇组合物
EP3030266B1 (en) 2013-08-08 2020-10-28 Novan Inc. Topical compositions and methods of using the same
KR20160040207A (ko) * 2013-08-09 2016-04-12 더 케무어스 컴퍼니 에프씨, 엘엘씨 환형 다이에스테르를 갖는 피부 케어 조성물 및 이의 방법
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
HUE050603T2 (hu) 2015-06-18 2020-12-28 Bausch Health Ireland Ltd Egy kortikoszteroidot és egy retinoidot tartalmazó topikális készítmények psoriasis kezelésére
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
EP3143986A1 (en) 2015-09-21 2017-03-22 Zimmer MedizinSysteme GmbH Hydrophilic gel for topical delivery of 5-aminolevulinic acid and production thereof
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
BR112021002656A2 (pt) * 2018-08-16 2021-05-11 Dr. Reddy's Laboratories Limited composições oleaginosas tópicas
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
JP7631212B2 (ja) 2019-02-27 2025-02-18 オティカラ,インコーポレーテッド 鼻、副鼻腔、および鼻咽頭組織の感染および/または炎症を治療するための方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US4017615A (en) 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
DE2964471D1 (en) * 1979-06-08 1983-02-17 Toko Yakuhin Kogyo Kk Creamy preparation containing steroid and process for the preparation thereof
JPS58225009A (ja) 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
JPS6136219A (ja) * 1984-07-27 1986-02-20 Shiseido Co Ltd 皮膚外用剤
US4879119A (en) * 1984-02-21 1989-11-07 Yamanouchi Pharmaceutical Co., Ltd. Patch
US4831023A (en) * 1986-06-27 1989-05-16 Thames Pharmacal Co., Inc. Water washable vehicles for topical use
JPH0676328B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイドクリ−ム製剤
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
EP0746301A1 (en) * 1992-11-23 1996-12-11 Estee Lauder Inc. Self-tanning cosmetic compositions and methods of using the same
US6300326B1 (en) 1994-11-02 2001-10-09 Michael R. Dobbs Composition and method for control and treatment of cutaneous inflammation
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
JPH10204001A (ja) * 1996-11-15 1998-08-04 Kao Corp 経皮吸収促進剤
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
JPH11158060A (ja) * 1997-11-18 1999-06-15 Bristol Myers Squibb Co 長期間貯蔵される組成物中の医薬及び/又は透過増強剤が不安定なときに透過増強剤により医薬の皮膚透過を増強させる方法及び組成物
US6066281A (en) * 1998-06-16 2000-05-23 Velcro Industries B.V. Fastener products and their production
AU1803100A (en) * 1999-01-06 2000-07-24 Taisho Pharmaceutical Co., Ltd. Amelometasone lotion
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
TW200522932A (en) * 2003-09-15 2005-07-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines

Similar Documents

Publication Publication Date Title
CA2471041A1 (en) Compositions and methods for enhancing corticosteriod delivery
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
JP2024057010A5 (cg-RX-API-DMAC7.html)
US5807568A (en) Enhanced delivery of topical compositions containing flurbiprofen
JP2022058765A5 (cg-RX-API-DMAC7.html)
JP2003512427A5 (cg-RX-API-DMAC7.html)
KR900700099A (ko) 국소투여 메트로니다졸 제형 및 이의 치료학적 용도
CA2206303A1 (en) Matrix type patch formulation
RU2004118487A (ru) Тонкоизмельченный пленкообразующий порошок, содержащие его композиции, способы его получения и применения
CA2492976A1 (en) Solution for ungual and peri-ungual application
JP5290582B2 (ja) 爪用医薬組成物
CA2391076A1 (en) Solutions containing epinastin
MY101536A (en) Anti-inflammatory and analgesic tape for external use
JPH10152433A (ja) 被膜形成性抗真菌剤組成物
EP0331382B1 (en) Transdermal flux enhancing compositions
EP4218741A1 (en) Water-based adhesive patch comprising ketoprofen
JP2010189440A (ja) 爪用貼付剤
JP2005187328A (ja) イブプロフェン含有解熱鎮痛組成物、及び感冒薬
JP2002249422A (ja) スキンケア用貼付剤
WO2021216450A8 (en) Opioid antagonist formulations
JP2005535635A5 (cg-RX-API-DMAC7.html)
JP2548686B2 (ja) 外用薬剤組成物
JPH0231052B2 (cg-RX-API-DMAC7.html)
JP2023540664A5 (cg-RX-API-DMAC7.html)
WO1992020376A1 (fr) Composition de promoteur de l'absorption percutanee et preparation externe pour l'administration de medicaments par voie percutanee